Plus Therapeutics, Inc.

Plus Therapeutics, Inc.

PSTV · Nasdaq

Plus Therapeutics, Inc. (PSTV) is a Biotechnology company in the Healthcare sector, listed on Nasdaq. This page provides the complete earnings calendar, dividend schedule, and financial data for Plus Therapeutics, Inc. in 2026.

Earnings calendar

Next earnings date

—

Not scheduled

EPS estimate

—

Revenue estimate

—

Past earnings

19 Aug 2026
EPS actual
—
estimate -0.88
Revenue actual
—
estimate 1.1M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
15 May 2026
EPS actual
-1.05 (-23.8%)
estimate -0.85
Revenue actual
1.0M (+5.5%)
estimate 974.0K
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
11 May 2026
EPS actual
—
estimate -0.85
Revenue actual
—
estimate 974.0K
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
12 Mar 2026
EPS actual
-0.03 (-4.2%)
estimate -0.03
Revenue actual
1.4M (+10.6%)
estimate 1.2M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
30 Oct 2025
EPS actual
-0.04 (-100.0%)
estimate -0.02
Revenue actual
1.4M (-6.5%)
estimate 1.5M
Price reaction
1d
+2.37%
5d
-2.41%
30d
+4.37%
Sign in to view returns
Beat Miss usd

Dividend calendar

No dividend history available.

EPS (Earnings Per Share)

Revenue

Company profile

Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It has a license agreement with NanoTx, Corp. to develop and commercialize NanoTx's glioblastoma treatment. The company was formerly known as Cytori Therapeutics, Inc. and changed its name to Plus Therapeutics, Inc. in July 2019. Plus Therapeutics, Inc. was founded in 1996 and is headquartered in Austin, Texas.

Sector
Healthcare
Industry
Biotechnology
Country
United States
Exchange
Nasdaq
CEO
Marc H. Hedrick
Employees
21
IPO date
11 Jul 2001
ISIN
US72941H5090
Website
plustherapeutics.com

Frequently asked questions

What was Plus Therapeutics, Inc.'s most recent earnings date?

Plus Therapeutics, Inc. (PSTV) last reported earnings on August 19, 2026.

Where is Plus Therapeutics, Inc. stock listed?

Plus Therapeutics, Inc. (PSTV) is listed on Nasdaq.